PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33688584-3	2021	Comparing to those under trial/temporarily used antivirus drugs (i.e., umifenovir, lopinavir), ceftriaxone, cefotaxime, and cefuroxime show higher binding affinities to the N-terminal domain of N protein (N-NTD), C-terminal domain of N protein (N-CTD), and receptor-binding domain of S protein (S-RBD).	Lopinavir	83-92	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	284-285	
33531790-12	2021	This finding was of particular importance that other compounds including hydroxychloroquine sulphate, lopinavir and ivermectin could bind with the spike protein only by weak Vander wall bonds and no hydrogen bond formation was noticed.	Lopinavir	102-111	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	147-152	
33679150-5	2021	In this study, we docked five clinically used drug molecules, favipiravir, hydroxychloroquine, remdesivir, lopinavir, and ritonavir onto three target proteins, the receptor-binding domain of SARS-CoV-2 spike protein, SARS-CoV-2 main protease, and human furin protease.	Lopinavir	107-116	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	202-207	
32729392-4	2021	Molecular docking on 40 derivatives of standard drugs (Remdesivir, Lopinavir and Theophylline) led to the identification of R10, R2 and L9 as potential inhibitors of 3CLpro, PLpro and Spike protein, respectively.	Lopinavir	67-76	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	184-189